The acquisition of Diros Technology by Avanos Medical is expected to have a positive short-term impact on AVNS stock price. The deal is expected to be immediately accretive to revenue growth, gross margins, operating margins, and EPS, which are key financial metrics for investors. This news is highly relevant and important for AVNS investors, and the confidence in this analysis is high based on the information provided in the article.